These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35430758)

  • 1. Cancer testis antigen (PRAME) as an independent marker for survival in oral squamous cell carcinoma (OSCC).
    Haidari S; Tröltzsch M; Fliefel R; Jungbluth AA; Otto S; Fegg F; Liokatis P; Ahmadi N; Eberl M; Probst FA; Knösel T
    J Oral Pathol Med; 2022 May; 51(5):421-428. PubMed ID: 35430758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-testis antigen expression in synovial sarcoma: NY-ESO-1, PRAME, MAGEA4, and MAGEA1.
    Iura K; Maekawa A; Kohashi K; Ishii T; Bekki H; Otsuka H; Yamada Y; Yamamoto H; Harimaya K; Iwamoto Y; Oda Y
    Hum Pathol; 2017 Mar; 61():130-139. PubMed ID: 27993576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of PRAME and NY-ESO-1 as potential therapeutic and prognostic biomarkers in triple-negative breast carcinomas.
    See SHC; Smith SH; Finkelman BS; LaBoy C; Novo JE; Siziopikou KP; Blanco LZ
    Pathol Res Pract; 2023 Jan; 241():154299. PubMed ID: 36603407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer Testis Antigens and Immunotherapy: Expression of PRAME Is Associated with Prognosis in Soft Tissue Sarcoma.
    Albertsmeier M; Altendorf-Hofmann A; Lindner LH; Issels RD; Kampmann E; Dürr HR; Schubert-Fritschle G; Angele MK; Kirchner T; Jungbluth AA; Knösel T
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33287125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PRAME expression in head and neck cancer correlates with markers of poor prognosis and might help in selecting candidates for retinoid chemoprevention in pre-malignant lesions.
    Szczepanski MJ; DeLeo AB; Łuczak M; Molinska-Glura M; Misiak J; Szarzynska B; Dworacki G; Zagor M; Rozwadowska N; Kurpisz M; Krzeski A; Kruk-Zagajewska A; Kopec T; Banaszewski J; Whiteside TL
    Oral Oncol; 2013 Feb; 49(2):144-51. PubMed ID: 22944049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous cytoplasmic and nuclear protein expression of melanoma antigen-A family and NY-ESO-1 cancer-testis antigens represents an independent marker for poor survival in head and neck cancer.
    Laban S; Atanackovic D; Luetkens T; Knecht R; Busch CJ; Freytag M; Spagnoli G; Ritter G; Hoffmann TK; Knuth A; Sauter G; Wilczak W; Blessmann M; Borgmann K; Muenscher A; Clauditz TS
    Int J Cancer; 2014 Sep; 135(5):1142-52. PubMed ID: 24482145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemistry of YAP and dNp63 and survival analysis of patients bearing precancerous lesion and oral squamous cell carcinoma.
    Ono S; Nakano K; Takabatake K; Kawai H; Nagatsuka H
    Int J Med Sci; 2019; 16(5):766-773. PubMed ID: 31217745
    [No Abstract]   [Full Text] [Related]  

  • 8. Hormone receptors AR, ER, PR and growth factor receptor Her-2 expression in oral squamous cell carcinoma: Correlation with overall survival, disease-free survival and 10-year survival in a high-risk population.
    Adnan Y; Ali SMA; Awan MS; Idress R; Awan MO; Farooqui HA; Kayani HA
    PLoS One; 2022; 17(5):e0267300. PubMed ID: 35544472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and clinical significance of MAGE and NY-ESO-1 cancer-testis antigens in adenoid cystic carcinoma of the head and neck.
    Veit JA; Heine D; Thierauf J; Lennerz J; Shetty S; Schuler PJ; Whiteside T; Beutner D; Meyer M; Grünewald I; Ritter G; Gnjatic S; Sikora AG; Hoffmann TK; Laban S
    Head Neck; 2016 Jul; 38(7):1008-16. PubMed ID: 26874246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.
    Guo H; Li C; Su X; Huang X
    Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843
    [No Abstract]   [Full Text] [Related]  

  • 11. Zinc finger AN1-type containing 4 is a novel marker for predicting metastasis and poor prognosis in oral squamous cell carcinoma.
    Kurihara-Shimomura M; Sasahira T; Nakamura H; Nakashima C; Kuniyasu H; Kirita T
    J Clin Pathol; 2018 May; 71(5):436-441. PubMed ID: 29074611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
    Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
    Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FLOT-2 is an independent prognostic marker in oral squamous cell carcinoma.
    Wen Q; Alnemah MM; Luo J; Wang W; Chu S; Chen L; Li J; Xu L; Li M; Zhou J; Fan S
    Int J Clin Exp Pathol; 2015; 8(7):8236-43. PubMed ID: 26339392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The level and clinical significance of 5-hydroxymethylcytosine in oral squamous cell carcinoma: An immunohistochemical study in 95 patients.
    Wang Y; Hu H; Wang Q; Li Z; Zhu Y; Zhang W; Wang Y; Jiang H; Cheng J
    Pathol Res Pract; 2017 Aug; 213(8):969-974. PubMed ID: 28554766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Spatially Heterogeneous Trop-2 Expression on Prognosis in Oral Squamous Cell Carcinoma.
    Erber R; Spoerl S; Mamilos A; Krupar R; Hartmann A; Ruebner M; Taxis J; Wittenberg M; Reichert TE; Spanier G; Spoerl S
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-testis antigens PRAME and NY-ESO-1 correlate with tumour grade and poor prognosis in myxoid liposarcoma.
    Iura K; Kohashi K; Hotokebuchi Y; Ishii T; Maekawa A; Yamada Y; Yamamoto H; Iwamoto Y; Oda Y
    J Pathol Clin Res; 2015 Jul; 1(3):144-59. PubMed ID: 27499900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic adenocarcinoma up-regulated factor has oncogenic functions in oral squamous cell carcinoma.
    Sasahira T; Kurihara M; Nishiguchi Y; Nakashima C; Kirita T; Kuniyasu H
    Histopathology; 2017 Mar; 70(4):539-548. PubMed ID: 27706833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and therapeutic relevance of NY-ESO-1 expression in oral squamous cell carcinoma.
    Ries J; Mollaoglu N; Vairaktaris E; Neukam FW; Nkenke E
    Anticancer Res; 2009 Dec; 29(12):5125-30. PubMed ID: 20044626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NYESO-1/LAGE-1s and PRAME are targets for antigen specific T cells in chondrosarcoma following treatment with 5-Aza-2-deoxycitabine.
    Pollack SM; Li Y; Blaisdell MJ; Farrar EA; Chou J; Hoch BL; Loggers ET; Rodler E; Eary JF; Conrad EU; Jones RL; Yee C
    PLoS One; 2012; 7(2):e32165. PubMed ID: 22384167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of Photodynamic Therapy on the Expression of Cancer/Testis Antigens in Squamous Cell Carcinoma of the Head and Neck.
    Theodoraki MN; Lorenz KJ; Schneider J; Thierauf JC; Spagnoli G; Schuler PJ; Hoffmann TK; Laban S
    Anticancer Res; 2016 Aug; 36(8):3973-82. PubMed ID: 27466502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.